Cardiac MRI and blood markers sharpen hypertrophic cardiomyopathy risk prediction

MedicalXpress | Mai 11, 2026

Findings from a new study have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart condition with a prevalence of one in 500 people and a frequent cause of sudden cardiac death. Specifically, the findings demonstrate that incorporating prospective data including clinical history, imaging, and blood biomarker data into risk assessment can improve prediction of adverse cardiac events in people with HCM.